Lancet · 2017

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, De Marinis F, Turna H, Lee JS, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR, OAK Study Group.

Show affiliations
  • Rittmeyer ALungenfachklinik Immenhausen, Immenhausen, Germany.
  • Barlesi FAix Marseille Universite, Assistance Publique Hôpitaux de Marseille, Marseille, France.
  • Waterkamp DGenentech, Inc., South San Francisco, CA, USA.
  • Park KSamsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Ciardiello FSeconda Università degli Studi di Napoli, Napoli, Italy.
  • von Pawel JAsklepios Fachkliniken München-Gauting, Gauting, Germany.
  • Gadgeel SMKarmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
  • Hida TAichi Cancer Center Hospital, Nagoya, Japan.
  • Kowalski DMOncology Centre, Institute M Sklodowska-Curie, Warsaw, Poland.
  • Dols MCMedical Oncology Section, Hospital Regional Universitario Carlos Haya, Málaga, Spain.
  • Cortinovis DLMedical Oncology Unit, AOU San Gerardo, Monza, Italy.
  • Leach JMinnesota Oncology, Minneapolis, MN, USA.
  • Polikoff JSouthern California Permanente Medical Group, San Diego, CA, USA.
  • Barrios CPUCRS School of Medicine, Porto Alegre, Brazil.
  • Kabbinavar FUniversity of California, Los Angeles, Los Angeles, CA, USA.
  • Frontera OACentro Internacional de Estudios Clinicos, Santiago, Chile.
  • De Marinis FEuropean Institute of Oncology, Milan, Italy.
  • Turna HIstanbul University Cerrahpasa Medical Faculty Hospital, Medical Oncology, Istanbul, Turkey.
  • Lee JSSeoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Ballinger MGenentech, Inc., South San Francisco, CA, USA.
  • Kowanetz MGenentech, Inc., South San Francisco, CA, USA.
  • He PGenentech, Inc., South San Francisco, CA, USA.
  • Chen DSGenentech, Inc., South San Francisco, CA, USA.
  • Sandler AGenentech, Inc., South San Francisco, CA, USA.
  • Gandara DRUC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: drgandara@ucdavis.edu.
52 read9 want to readRigor 3.1Novelty 2.9Impact 3.1Reprod. 3.0

Most-cited papers citing this

  • J Hematol Oncol · 2025 · cited by 3
  • Nat Rev Cancer · 2026 · cited by 2
  • Ann Oncol · 2026 · cited by 2
  • Adv Sci (Weinh) · 2026 · cited by 2
  • Cancer Cytopathol · 2026 · cited by 1

Log in to like, log, and share thoughts on this paper.

Discussion

Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.

0

Yuki Sato

Rigor 4/5Novelty 1/5Impact 2/5Reprod. 5/5

Solid methods, convincing results.

0

Lena Khan

Rigor 2/5Novelty 5/5Impact 3/5Reprod. 3/5

Replication is unclear to me.

0

Mei Cohen

Rigor 5/5Novelty 2/5Impact 4/5Reprod. 1/5

Replication is unclear to me.

0

Ravi Cohen

Rigor 5/5Novelty 1/5Impact 4/5Reprod. 4/5

Interesting idea, small sample.

0

Eva Kim

Rigor 1/5Novelty 3/5Impact 1/5Reprod. 3/5

Solid methods, convincing results.

0

Ken Garcia

Rigor 5/5Novelty 5/5Impact 5/5Reprod. 4/5

Replication is unclear to me.

0

Liam Patel

Rigor 1/5Novelty 2/5Impact 5/5Reprod. 5/5

Important contribution to the field.

0

Nadia Lee

Rigor 3/5Novelty 5/5Impact 2/5Reprod. 3/5

Great figures and clear story.

0

Ines Garcia

Rigor 1/5Novelty 1/5Impact 1/5Reprod. 1/5

Great figures and clear story.

0

Mei Lee

Rigor 3/5Novelty 1/5Impact 2/5Reprod. 4/5

Great figures and clear story.